Implementation of a stereotactic body radiotherapy program for unresectable pancreatic cancer in an integrated community academic radiation oncology satellite network

by Alexander Augustyn, Valerie I. Reed, Neelofur Ahmad, Manoop S. Bhutani, Elizabeth S. Bloom, John R. Bowers, Gregory M. Chronowski, Prajnan Das, Emma B. Holliday, Marc E. Delclos, Ryan W. Huey, Eugene J. Koay, Sunyoung S. Lee, Christopher L. Nelson, Cullen M. Taniguchi, Albert C. Koong, Stephen G. Chun
Published 2021-03-01

Phase I Trial of Consolidative Radiotherapy with Concurrent Bevacizumab, Erlotinib and Capecitabine for Unresectable Pancreatic Cancer.

by Awalpreet S Chadha, Heath D Skinner, Jillian R Gunther, Mark F Munsell, Prajnan Das, Bruce D Minsky, Marc E Delclos, Deyali Chatterjee, Huamin Wang, Marilyn Clemons, Geena George, Pankaj K Singh, Matthew H Katz, Jason B Fleming, Milind M Javle, Robert A Wolff, Gauri R Varadhachary, Christopher H Crane, Sunil Krishnan
Published 2016-01-01

Preoperative radiation dose escalation for rectal cancer using a concomitant boost strategy improves tumor downstaging without increasing toxicity: A matched-pair analysis

by Jillian R. Gunther, MD, PhD, Awalpreet S. Chadha, MD, Ui Sup Shin, MD, In Ja Park, MD, Kiran V. Kattepogu, MD, Jonathan D. Grant, MD, David C. Weksberg, MD, PhD, Cathy Eng, MD, Scott E. Kopetz, MD, PhD, Prajnan Das, MD, MS, MPH, Marc E. Delclos, MD, Harmeet Kaur, MD, Dipen M. Maru, MD, John M. Skibber, MD, Miguel A. Rodriguez-Bigas, MD, Y. Nancy You, MD, Sunil Krishnan, MD, George J. Chang, MD, MS
Published 2017-07-01